Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia

NCT04982354 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Could not accrue

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: CPX-351
DRUG: Midostaurin
DRUG: Busulfan
DRUG: Melphalan
DRUG: Fludarabine
BIOLOGICAL: CD34+ selected allogeneic stem cell transplant from an HLA-compatible donor

Sponsor

Guenther Koehne

Collaborators

[object Object]